ArticleACS medicinal chemistry letters2026

Targeted Degradation of KAT6A: Expanding the Therapeutic Frontier of Epigenetic Drug Discovery.

Anna C Renner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.